Healing of spongiosus-cutaneous fistula with hyperbaric Oxygen Therapy (HBOT): a case report

Urologia
Pier A Della CameraAlessandro Natali

Abstract

We present a case of a spongiosus-cutaneous fistula in a 39-year-old man with recurrent episodes of cutaneous abscess in dorsal middle third penis (5 × 3 cm) treated with Hyperbaric Oxygen Therapy (HBOT). After emptying nodular abscess, the patient was noncompliant for further surgery. Therefore, it was suggested the association between HBOT and antibiotic therapy. HBOT is carried out in a hyperbaric room, where the internal pressure is increased (compression phase) by entering compressed air up to 283.71 kPa in about 10 minutes. Every HBOT cycle lasted 24 days in which the patient had been taking Amoxicillin/Clavulanic Acid 875 mg/125 mg 3 tabs/day and Sulfamethoxazole/Trimethoprim 160 mg/800 mg 2 tabs/day for 2 weeks. At the end of the treatment, a penile magnetic resonance imaging and an ultrasonography were executed and they evidenced a complete remission of the lesion. In the subsequent 22 months, there was no recurrence. Our results suggest that HBOT is an effective treatment for chronic wounds, including a spongiosus-cutaneous fistula of unknown cause, when used in combination with conventional standard therapy or further interventions. At present time, the gold standard remains surgery; nevertheless, our experience with...Continue Reading

References

Jan 1, 1987·Diabetes Care·G BaroniF Favales
Apr 1, 1997·International Journal of Oral and Maxillofacial Surgery·P C TompachJ L Stoll
Sep 17, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Nam C YuZoran Barbaric
Apr 11, 2006·TheScientificWorldJournal·Noori S Al-Waili, Glenn J Butler
Jan 18, 2016·International Journal of Antimicrobial Agents·Mette KolpenPeter Østrup Jensen
Apr 29, 2016·The Cochrane Database of Systematic Reviews·Michael H BennettChristopher Milross

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society
Mikel Gray, Catherine R Ratliff
The Cochrane Database of Systematic Reviews
P KrankeSebastian E Debus
Wounds : a Compendium of Clinical Research and Practice
Laura Bolton
Masui. The Japanese journal of anesthesiology
K TakahashiK Iwatsuki
Annali italiani di chirurgia
G ValenteF Petruzzi
© 2022 Meta ULC. All rights reserved